NCT04674267 2026-03-18
REACH
Dana-Farber Cancer Institute
Phase NA Recruiting
Clinical Trials
31 trialsNCT05187182 2026-03-18
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
Washington University School of Medicine
Phase 1 Recruiting
NCT06408220 2026-03-13
Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer
City of Hope Medical Center
Phase NA Recruiting
NCT07320586 2026-03-13
Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer
Shandong Tumor Hospital
Phase 2 Recruiting
NCT07464470 2026-03-12
GENCONCOR-2
Blokhin's Russian Cancer Research Center
Recruiting
NCT07467174 2026-03-12
REPROG-RCT
Yonsei University
Phase 4 Not yet recruiting
NCT07139418 2026-03-11
The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy
First Affiliated Hospital of Zhejiang University
Recruiting
NCT06807372 2026-03-10
Validation of a Model for Predicting Duodenal Stump Leakage After Gastrectomy
First Affiliated Hospital of Zhejiang University
Active not recruiting
NCT05183126 2026-03-06
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
University of Michigan Rogel Cancer Center
Phase 4 Recruiting
NCT05871099 2026-03-06
Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
The Affiliated Hospital of Qingdao University
Phase 3 Recruiting
NCT07070466 2026-03-06
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
Massachusetts General Hospital
Phase 2 Recruiting
NCT07453433 2026-03-06
Submucosal Pressure Ejection Endoscopic Dissection for Early Gastric Cancer: a Retrospective Cohort Study
Shanghai East Hospital
Completed
NCT00899626 2026-03-05
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
Vanderbilt University Medical Center
Recruiting
NCT07452471 2026-03-05
TAP-WELPASS
Pusan National University Yangsan Hospital
Phase NA Not yet recruiting
NCT07448493 2026-03-04
GASTROBRAIN
Blokhin's Russian Cancer Research Center
Active not recruiting
NCT06461910 2026-03-03
Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting
NCT06686966 2026-03-03
Prediction of Postoperative Complications and Survival in Gastric Cancer Using Preoperative Blood Markers
First Affiliated Hospital of Chongqing Medical University
Completed
NCT07447050 2026-03-03
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
University of California, Irvine
Phase 2 Recruiting
NCT03686488 2026-03-02
TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT06346197 2026-03-02
CIME
Centre Leon Berard
Phase 3 Recruiting
NCT07441850 2026-03-02
Digital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant Therapy
Beijing Friendship Hospital
Phase NA Recruiting
NCT07307560 2026-02-27
High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients
Zhejiang University
Phase NA Recruiting
NCT07401303 2026-02-27
Full-time RDI for ESD: Impact on Major Adverse Events and Procedure Time
Xijing Hospital of Digestive Diseases
Phase NA Not yet recruiting
NCT07437573 2026-02-27
KLASS-09
Korea University Guro Hospital
Phase 3 Completed
NCT06896370 2026-02-25
An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori
Fudan University
Recruiting
NCT06943794 2026-02-25
Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial
Fudan University
Phase NA Not yet recruiting
NCT06943807 2026-02-25
Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis
Fudan University
Recruiting
NCT07277439 2026-02-24
Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting
NCT05567835 2026-02-23
TOGAR
Baylor College of Medicine
Phase 2 Terminated
NCT04907643 2026-02-20
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Cedars-Sinai Medical Center
Phase NA Recruiting
NCT02248519 2026-02-19
LOGICA
UMC Utrecht
Phase NA Completed